BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2340778)

  • 1. Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent.
    Powell BL; Gregory BW; Kute TE; Morgan TM; Lyerly ES; Capizzi RL
    Cytometry; 1990; 11(3):438-41. PubMed ID: 2340778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry.
    Tsurusawa M; Aoyama M; Saeki K; Fujimoto T
    Leukemia; 1995 Nov; 9(11):1921-5. PubMed ID: 7475284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
    Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine.
    Sasaki K; Murakami T; Ogino T; Takahashi M; Kawasaki S
    Cytometry; 1986 Jul; 7(4):391-5. PubMed ID: 3089742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokinetic analysis of lung cancer by bromodeoxyuridine labeling of cytology specimens.
    ten Velde GP; Schutte B; Reijnders MM; Bosman FT; Blijham GH
    Cytometry; 1989 Nov; 10(6):807-10. PubMed ID: 2582973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells.
    Powell BL; White JC; Gregory BW; Brockschmidt JK; Rhinehardt-Clark A; Lyerly ES; Chorley HM; Capizzi RL
    Leukemia; 1991 Jul; 5(7):598-601. PubMed ID: 2072744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric determination with bromodeoxyuridine/DNA assay of sensitivity of S-phase cells to cytosine arabinoside in childhood acute lymphoblastic leukemia.
    Katano N; Tsurusawa M; Niwa M; Fujimoto T
    Am J Pediatr Hematol Oncol; 1989; 11(4):411-6. PubMed ID: 2618975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
    Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.
    Duque RE; Andreeff M; Braylan RC; Diamond LW; Peiper SC
    Cytometry; 1993; 14(5):492-6. PubMed ID: 8354121
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
    Ellwart J; Dörmer P
    Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
    Karp JE; Ross DD; Yang W; Tidwell ML; Wei Y; Greer J; Mann DL; Nakanishi T; Wright JJ; Colevas AD
    Clin Cancer Res; 2003 Jan; 9(1):307-15. PubMed ID: 12538483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
    Waldman FM; Dolbeare F; Gray JW
    Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.
    Nüsse M; Afzal SM; Carr B; Kavanau K
    Cytometry; 1985 Nov; 6(6):611-9. PubMed ID: 4064841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.